Recently, the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Commerce, the Health Planning Commission, and the State Food and Drug Administration jointly issued the "Guidelines for the Development of the Pharmaceutical Industry" (hereinafter referred to as the "Guide"), aiming to speed up the "13th Five-Year" pharmaceutical industry from large to strong. The transformation.
The "Guide" proposes to promote the development of six major areas in the pharmaceutical industry, including biopharmaceuticals, new chemical drugs, high-quality Chinese medicines, high-performance medical devices, new auxiliary materials and pharmaceutical equipment. Among the six major areas, the latter three are related to medical devices, which accounts for half of the total.
Specific to each medical equipment sub-area, the key development targets are as follows:
First, medical equipment
1. Medical imaging equipment.
Focus on the development of high field strength superconducting magnetic resonance and specialist superconducting magnetic resonance imaging systems, high-end CT equipment, multimodal fusion molecular imaging equipment PET-CT and PET-MRI, high-end color Doppler ultrasound and intravascular ultrasound, blood vessel numbers Subtractive X-ray machine (DSA), high-definition electronic endoscope, etc.
Improve the production level of core components, including CT tube, magnetic resonance superconducting magnet and RF coil, PET crystal detector, ultrasonic single crystal probe, two-dimensional array probe and other new probes, X-ray flat panel detector, endoscope three Wafer camera system, etc.
2. In vitro diagnostic products.
Focus on the development of high-throughput biochemical analyzers, immunoassays, blood cell analyzers, laboratory-wide automated inspection and analysis lines (TLA) and related reagents, single-molecule gene sequencers and other molecular diagnostic instruments, and new real-time detection equipment (POCT) .
Strengthen the integration and innovation of in vitro diagnostic equipment, testing reagents, information management software and data analysis systems, accelerate the establishment of testing reagent standards, the development of standard materials for traceability and the development of new reagents.
3. Treatment equipment .
Focus on the development of high-energy linear accelerators and image-guided radiotherapy devices, orthopedic and laparoscopic surgery robots, hemodialysis equipment and consumables, artificial liver blood purification equipment and consumables, ophthalmic laser treatment systems, high-end therapeutic ventilators, mobile ICU emergency systems, defibrillation Instrument, Chinese medicine treatment equipment, etc.
4. Implanted interventional products and medical materials.
Focus on the development of fully degradable coronary stents, heart valves, degradable occluders, reusable interventional device catheters, artificial joints and spine, 3D printed orthopedic implants, tissue-induced regeneration and repair materials, cardiac pacemakers , implantable left ventricular assist device, brain pacemaker, cochlear implant, dental implant, ophthalmic intraocular lens, functional dressing, degradable rapid hemostatic material and medical adhesive.
5. Mobile medical products.
Develop and apply health care big data , focus on the development of telemedicine systems, wearable physiological information monitoring equipment, home, pension and rehabilitation equipment with cloud services and artificial intelligence functions, provide health consultation, online appointment triage, case follow-up, test results Query health management information systems for applications such as.
Develop core common components such as new electrophysiological sensors, flexible display devices, and high-performance batteries for use in wearable medical devices.
For the Sports Nutrition and food supplement market, we have created a range of unique high-quality ingredients. All of Our protein is certified to applicable organic standards: National Organic Program (NOP) and European Union (EU), in order to ensure that your product benefits from optimal positioning, whether you operate on a global or local scale, we`ll work to keep you ahead of trends and improve your profitability.
Plant Protein,Organic Rice,Brown Rice Protein,Pumpkin Seed Protein
Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com